CTS (NYSE: CTS ) reported earnings on Jan. 28. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), CTS missed estimates on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP earnings per share grew significantly.
Gross margins grew, operating margins shrank, net margins grew.
Revenue details
CTS chalked up revenue of $138.3 million. The three analysts polled by S&P Capital IQ expected net sales of $142.8 million on the same basis. GAAP reported sales were 4.0% lower than the prior-year quarter's $144.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $0.18. The three earnings estimates compiled by S&P Capital IQ forecast $0.24 per share. GAAP EPS of $0.26 for Q4 were 53% higher than the prior-year quarter's $0.17 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 19.4%, 130 basis points better than the prior-year quarter. Operating margin was -0.5%, 330 basis points worse than the prior-year quarter. Net margin was 6.4%, 230 basis points better than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $164.0 million. On the bottom line, the average EPS estimate is $0.18.
Next year's average estimate for revenue is $636.8 million. The average EPS estimate is $0.82.
Investor sentiment
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CTS is buy, with an average price target of $13.50.
If you're interested in companies like CTS, you might want to check out the jaw-dropping technology that's about to put 100 million Chinese factory workers out on the street � and the 3 companies that control it. We'll tell you all about them in "The Future is Made in America." Click here for instant access to this free report.
- Add CTS to My Watchlist.
No comments:
Post a Comment